Clinical trials
Completed Diabetes Mellitus, Type 2 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
391 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 12 |
| 2007 | 16 |
| 2008 | 29 |
| 2009 | 34 |
| 2010 | 40 |
| 2011 | 18 |
| 2012 | 17 |
| 2013 | 26 |
| 2014 | 16 |
| 2015 | 22 |
| 2016 | 18 |
| 2017 | 13 |
| 2018 | 13 |
| 2019 | 11 |
| 2020 | 19 |
| 2021 | 13 |
| 2022 | 16 |
| 2023 | 22 |
| 2024 | 15 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 391 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 41 |
| Chong Kun Dang Pharmaceutical | 39 |
| AstraZeneca | 35 |
| Eli Lilly and Company | 27 |
| Boehringer Ingelheim | 26 |
| Sanofi | 21 |
| Handok Inc. | 14 |
| GlaxoSmithKline | 12 |
| Boryung Pharmaceutical Co., Ltd | 9 |
| Seoul National University Bundang Hospital | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 391 |
| Diabetes Mellitus | 74 |
| Hyperglycemia | 9 |
| Diabetes Mellitus, Type 1 | 8 |
| Hypertension | 8 |
| Insulin Resistance | 8 |
| Dyslipidemias | 7 |
| Obesity | 7 |
| Metabolic Diseases | 6 |
| Overweight | 6 |
Trials
Showing 1 to 25 of 391. Each trial links to its page on Pharma Observatory.
291 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.